Financhill
Back

Bone Biologics Stock Predictions

Bone Biologics Stock Forecast

  • Is Bone Biologics Stock Undervalued?
    The current Bone Biologics [BBLG] share price is $1.18. The Score for BBLG is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • BBLG is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Bone Biologics Stock Go Up Next Year?

Data Unavailable

Bone Biologics Stock Rating

Data Unavailable

Bone Biologics Stock Price History

Is BBLG stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBLG is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bonebiologics.com

52-Week Data

52-Week High:
10.56
52-Week Low:
0.80

Prediction Charts

Market Cap:
2.13M
Price in USD:
1.18
Volume:
87.32K
Beta:
0.45

Technical Analysis

SMA50:
1.63
SMA100:
1.56
SMA200:
1.87
52-Wk Change:
-70.5%

Stock Predictions

  • Is Bone Biologics stock public?
    Yes, Bone Biologics is a publicly traded company.
  • What is the Bone Biologics stock quote today?
    The Bone Biologics stock price is 1.18 USD today.
  • How to buy Bone Biologics stock online?
    You can buy Bone Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 1.65 1.73 1.75 1.63
Oct-28 1.79 1.73 1.79 1.66
Oct-29 1.66 1.39 1.71 1.20
Oct-30 1.37 1.35 1.42 1.31
Oct-31 1.34 1.39 1.39 1.30
Nov-1 1.36 1.30 1.38 1.29
Nov-4 1.30 1.29 1.34 1.25
Nov-5 1.34 1.39 1.41 1.31
Nov-6 1.39 1.28 1.40 1.25
Nov-7 1.29 1.30 1.34 1.26
Nov-8 1.30 1.36 1.38 1.30
Nov-11 1.34 1.32 1.36 1.30
Nov-12 1.27 1.20 1.35 1.20
Nov-13 1.20 1.18 1.21 1.14

Bone Biologics Earnings

Data Unavailable

Bone Biologics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.98 per share.

* Bone Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.